|
Saturday, May 31, 2025, Chicago, Illinois, 6:45 AM – 7:45 AM Central Time (7:45 AM – 8:45 AM Eastern Time)
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Clinical Care of Patients with Urothelial Bladder CancerA CME Symposium Held in Conjunction with the 2025 ASCO® Annual Meeting
Location
Hilton Chicago 720 South Michigan Avenue Chicago, Illinois Phone: (312) 922-4400 Program Schedule — Central Time 6:15 AM – 6:45 AM — Registration and Breakfast 6:45 AM – 7:45 AM — Educational Meeting Meeting Room Continental Room C (Lobby Level) Faculty
Andrea Necchi, MD Associate Professor Vita-Salute San Raffaele University Head of Genitourinary Medical Oncology IRCCS San Raffaele Hospital Milan, Italy Thomas Powles, MBBS, MRCP, MD Director of Barts Cancer Institute Queen Mary University of London London, United Kingdom
Moderator
Matthew D Galsky, MD Lillian and Howard Stratton Professor of Medicine Icahn School of Medicine at Mount Sinai Co-Leader, Bladder Cancer Center of Excellence Associate Director, Translational Research The Tisch Cancer Institute New York, New York This activity is supported by educational grants from Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Natera Inc.
Program Schedule — Central Time
6:15 AM – 6:45 AM — Registration and Breakfast 6:45 AM – 7:45 AM — Educational Meeting Topics to Be Discussed
Target Audience
CME Credit Form FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Prof Necchi — Advisory Committees: Bristol Myers Squibb, CatalYm, Daiichi Sankyo Inc, Genenta Science, Johnson & Johnson Pharmaceuticals, Merck; Consulting Agreements: AstraZeneca Pharmaceuticals LP, Gilead Sciences Inc, Johnson & Johnson Pharmaceuticals, Merck, Pfizer Inc, Samsung Bioepis; Contracted Research: AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Merck. Additional faculty to be announced. MODERATOR — Dr Galsky — Consulting Agreements: AbbVie Inc, AstraZeneca Pharmaceuticals LP, EMD Serono Inc, Gilead Sciences Inc, Janssen Biotech Inc, Merck, Pfizer Inc, Seagen Inc. RESEARCH TO PRACTICE CME PLANNING COMMITTEE MEMBERS, STAFF AND REVIEWERS This activity is supported by educational grants from Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Natera Inc. Hilton Chicago
This activity is intended for medical and radiation oncologists, urologists and other healthcare providers involved in the treatment of urothelial bladder cancer (UBC).
There is no registration fee for this event. For the in-person symposium in Chicago, preregistration is required as seating is limited. NOTICE: Registration for this event is independent of registration for the 2025 ASCO® Annual Meeting. IN-PERSON Registration for clinicians in practice/healthcare professionals
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. IN-PERSON Registrationfor clinicians » IN-PERSON Registration for other/industry professionals*
Please note, a limited number of seats are available to other/industry professionals on a first come, first served basis. IN-PERSON Registrationfor nonclinicians »
* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
WEBCAST Registration for all professionals
Please note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you require any physical, dietary or other accommodations, please call us at (800) 233-6153 before the event. Not an official event of the 2025 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer® the ASCO Foundation. |